Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLAID: Prophylactic Lisinopril for Anthracycline Cardiotoxicity
NCT03392740Phase 4Withdrawn
- Sponsor
- Ascension
- Start
- Mar 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in anthracycline-induced cardiomyopathy (AIC) comparing Lisinopril with Placebo (2 arms). Primary endpoint: Change in strain and strain rate parameters at 12 months. Planned start Mar 2018; status: withdrawn.
02
Drugs
lisinopril
03
Conditions
anthracycline-induced cardiomyopathy (AIC)
Beyond the preview
Go deeper on NCT03392740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03392740.